Global Anti-Rheumatic Drugs Market Growth (Status and Outlook) 2024-2030

Global Anti-Rheumatic Drugs Market Growth (Status and Outlook) 2024-2030


Anti-rheumatic drugs are medications used to treat rheumatic diseases, which are conditions characterized by inflammation, pain, stiffness, and swelling in the joints, muscles, and other connective tissues. Rheumatic diseases encompass a wide range of conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (SLE), and juvenile idiopathic arthritis, among others. The goals of treatment with anti-rheumatic drugs are to reduce inflammation, alleviate symptoms, prevent disease progression, and improve overall quality of life for patients.

The global Anti-Rheumatic Drugs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LPI (LP Information)' newest research report, the “Anti-Rheumatic Drugs Industry Forecast” looks at past sales and reviews total world Anti-Rheumatic Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-Rheumatic Drugs sales for 2023 through 2029. With Anti-Rheumatic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-Rheumatic Drugs industry.

This Insight Report provides a comprehensive analysis of the global Anti-Rheumatic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-Rheumatic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-Rheumatic Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-Rheumatic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-Rheumatic Drugs.

United States market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Anti-Rheumatic Drugs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Anti-Rheumatic Drugs players cover Novartis, UCB, AbbVie, Bristol-Myers Squibb, Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Rheumatic Drugs market by product type, application, key players and key regions and countries.

Segmentation by Type:
Disease Modifying Anti-rheumatics Drugs (DMARD's)
Nonsteroidal Anti-inflammatory Drugs (NSAID's)
Corticosteroids
Uric Acid Drugs
Others

Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Disease Modifying Anti-rheumatics Drugs (DMARD's)
Nonsteroidal Anti-inflammatory Drugs (NSAID's)
Corticosteroids
Uric Acid Drugs
Others

Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis
UCB
AbbVie
Bristol-Myers Squibb
Merck
HEYL Chemisch-pharmazeutische Fabrik
Roche
Johnson & Johnson
Amgen
Pfizer
GSK
Sanofi
Abbott Laboratories
Teva Pharmaceutical
Eli Lilly and Company
Celltrion
Astellas Pharma
Simcere
Daiichi Sankyo
Asahi Kasei

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Anti-Rheumatic Drugs Market Size by Player
4 Anti-Rheumatic Drugs by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Anti-Rheumatic Drugs Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings